- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT04888988
Testare gli effetti dell'esercizio sulla neuropatia periferica indotta dalla chemioterapia (CIPN)
Prova di fase II multicentrica randomizzata controllata di esercizio per il trattamento della neuropatia periferica indotta da chemioterapia (CIPN)
This phase II trial studies whether using exercise is better than the usual approach for treating chemotherapy-induced peripheral neuropathy (CIPN). CIPN occurs when chemotherapy damages the nerves communicating between the brain, spinal cord, and the rest of the body. The usual approach for treating CIPN is treatment with drugs that help reduce symptoms of other types of neuropathy (for example, from diabetes). However, these drugs do not treat all symptoms of CIPN. Exercise may help to reduce CIPN symptoms.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
PRIMARY OBJECTIVE:
I. Assess the preliminary efficacy of exercise versus (vs.) standard care for treating CIPN (via patient-reported CIPN-20 total score).
SECONDARY OBJECTIVES:
I. Assess the preliminary efficacy of exercise vs. standard care on individual symptoms of CIPN (via CIPN Symptom Inventory; i.e., numbness, tingling, burning/shooting pain, and cramping in the hands and feet).
II. Assess the preliminary efficacy of exercise vs. standard care on a clinical test of CIPN symptoms (via the tactile sensitivity in the fingers and toes).
III. Assess the effects of exercise vs. standard care on two possible CIPN mechanisms, namely interoception (via Multidimensional Assessment of Interoceptive Awareness version 2 [MAIA-2] questionnaire).
EXPLORATORY OBJECTIVES:
I. Assess the effects of exercise vs. standard care on other common symptoms related to cancer, chemotherapy, and CIPN, including:
Ia. Daily Diary of symptoms of CIPN. Ib. An array of cancer and treatment symptoms (MD Anderson Symptom Inventory; MDASI).
Ic. Anxiety and depression (hospital anxiety and depression scale; HADS). Id. Pain catastrophizing (pain catastrophizing scale; PCS). Ie. Cognitive impairment (Functional Assessment of Cancer Therapy-Cognitive [FACT-Cog]).
If. Fatigue (brief fatigue inventory; BFI). Ig. Quality of life (Functional Assessment of Cancer Therapy - General [FACT-G]).
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM 1 (EXERCISE): Participants undergo the exercise for cancer patients (EXCAP) intervention consisting of a home-based, self-directed, individually tailored progressive walking and resistance program for up to 6 weeks. Participants also undergo a tactile sensitivity test at baseline and after completion of EXCAP over 15-25 minutes. In addition, participants meet with a certified exercise instructor over 45 minutes at baseline and 2 additional booster meetings over 15-30 minutes during weeks 2 and 3 or weeks 4 and 5.
ARM 2 (CONTROL): Participants receive usual care for 6 weeks. At the end of the study, participants may receive the exercise kit and complete the EXCAP program as in Arm 1. Participants also undergo a tactile sensitivity test at baseline and after completion of EXCAP over 15-25 minutes.
Participants may optionally undergo magnetic resonance imaging (MRI) on study.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
California
-
Fresno, California, Stati Uniti, 93720
- Kaiser Permanente-Fresno
-
Martinez, California, Stati Uniti, 94553-3156
- Contra Costa Regional Medical Center
-
Roseville, California, Stati Uniti, 95661
- Kaiser Permanente-Roseville
-
Sacramento, California, Stati Uniti, 95814
- Kaiser Permanente Downtown Commons
-
Sacramento, California, Stati Uniti, 95823
- Kaiser Permanente-South Sacramento
-
San Jose, California, Stati Uniti, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Leandro, California, Stati Uniti, 94577
- Kaiser Permanente San Leandro
-
San Rafael, California, Stati Uniti, 94903
- Kaiser San Rafael-Gallinas
-
Santa Clara, California, Stati Uniti, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
South San Francisco, California, Stati Uniti, 94080
- Kaiser Permanente-South San Francisco
-
Vallejo, California, Stati Uniti, 94589
- Kaiser Permanente-Vallejo
-
Walnut Creek, California, Stati Uniti, 94596
- Kaiser Permanente-Walnut Creek
-
-
Colorado
-
Aurora, Colorado, Stati Uniti, 80012
- Rocky Mountain Cancer Centers-Aurora
-
Boulder, Colorado, Stati Uniti, 80303
- Boulder Community Foothills Hospital
-
Boulder, Colorado, Stati Uniti, 80304
- Rocky Mountain Cancer Centers-Boulder
-
Centennial, Colorado, Stati Uniti, 80112
- Rocky Mountain Cancer Centers - Centennial
-
Denver, Colorado, Stati Uniti, 80218
- Rocky Mountain Cancer Centers-Midtown
-
Denver, Colorado, Stati Uniti, 80220
- Rocky Mountain Cancer Centers-Rose
-
Denver, Colorado, Stati Uniti, 80218
- Colorado Blood Cancer Institute
-
Denver, Colorado, Stati Uniti, 80209
- The Women's Imaging Center
-
Englewood, Colorado, Stati Uniti, 80113
- Rocky Mountain Cancer Centers - Swedish
-
Englewood, Colorado, Stati Uniti, 80113
- The Melanoma and Skin Cancer Institute
-
Lakewood, Colorado, Stati Uniti, 80228
- Rocky Mountain Cancer Centers-Lakewood
-
Littleton, Colorado, Stati Uniti, 80120
- Rocky Mountain Cancer Centers-Littleton
-
Lone Tree, Colorado, Stati Uniti, 80124
- Rocky Mountain Cancer Centers-Sky Ridge
-
Longmont, Colorado, Stati Uniti, 80501
- Rocky Mountain Cancer Centers-Longmont
-
Thornton, Colorado, Stati Uniti, 80260
- Rocky Mountain Cancer Centers-Thornton
-
-
Delaware
-
Millville, Delaware, Stati Uniti, 19967
- Beebe South Coastal Health Campus
-
Newark, Delaware, Stati Uniti, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, Stati Uniti, 19713
- Medical Oncology Hematology Consultants PA
-
Rehoboth Beach, Delaware, Stati Uniti, 19971
- Beebe Health Campus
-
-
District of Columbia
-
Washington D.C., District of Columbia, Stati Uniti, 20010
- MedStar Washington Hospital Center
-
Washington D.C., District of Columbia, Stati Uniti, 20007
- MedStar Georgetown University Hospital
-
-
Hawaii
-
Honolulu, Hawaii, Stati Uniti, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Honolulu, Hawaii, Stati Uniti, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, Stati Uniti, 96813
- University of Hawaii Cancer Center
-
Honolulu, Hawaii, Stati Uniti, 96826
- Kapiolani Medical Center for Women and Children
-
‘Aiea, Hawaii, Stati Uniti, 96701
- Hawaii Cancer Care - Westridge
-
‘Aiea, Hawaii, Stati Uniti, 96701
- Pali Momi Medical Center
-
-
Illinois
-
Carterville, Illinois, Stati Uniti, 62918
- SIH Cancer Institute
-
Centralia, Illinois, Stati Uniti, 62801
- Centralia Oncology Clinic
-
Danville, Illinois, Stati Uniti, 61832
- Carle at The Riverfront
-
Decatur, Illinois, Stati Uniti, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Stati Uniti, 62526
- Cancer Care Specialists of Illinois - Decatur
-
Effingham, Illinois, Stati Uniti, 62401
- Crossroads Cancer Center
-
O'Fallon, Illinois, Stati Uniti, 62269
- Cancer Care Center of O'Fallon
-
Urbana, Illinois, Stati Uniti, 61801
- Carle Cancer Center
-
-
Iowa
-
Cedar Rapids, Iowa, Stati Uniti, 52403
- Oncology Associates at Mercy Medical Center
-
Cedar Rapids, Iowa, Stati Uniti, 52402
- Physicians' Clinic of Iowa PC
-
Des Moines, Iowa, Stati Uniti, 50314
- Mercy Medical Center - Des Moines
-
-
Maryland
-
Elkton, Maryland, Stati Uniti, 21921
- Christiana Care - Union Hospital
-
-
Michigan
-
Ann Arbor, Michigan, Stati Uniti, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Brighton, Michigan, Stati Uniti, 48114
- Trinity Health IHA Medical Group Hematology Oncology - Brighton
-
Brighton, Michigan, Stati Uniti, 48114
- Trinity Health Medical Center - Brighton
-
Canton, Michigan, Stati Uniti, 48188
- Trinity Health IHA Medical Group Hematology Oncology - Canton
-
Canton, Michigan, Stati Uniti, 48188
- Trinity Health Medical Center - Canton
-
Chelsea, Michigan, Stati Uniti, 48118
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
-
Chelsea, Michigan, Stati Uniti, 48118
- Chelsea Hospital
-
Grand Rapids, Michigan, Stati Uniti, 49503
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
-
Lansing, Michigan, Stati Uniti, 48912
- University of Michigan Health - Sparrow Lansing
-
Livonia, Michigan, Stati Uniti, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Ypsilanti, Michigan, Stati Uniti, 48197
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
-
-
Minnesota
-
Coon Rapids, Minnesota, Stati Uniti, 55433
- Mercy Hospital
-
Fridley, Minnesota, Stati Uniti, 55432
- Unity Hospital
-
Minneapolis, Minnesota, Stati Uniti, 55407
- Abbott-Northwestern Hospital
-
Saint Louis Park, Minnesota, Stati Uniti, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Paul, Minnesota, Stati Uniti, 55101
- Regions Hospital
-
Waconia, Minnesota, Stati Uniti, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, Stati Uniti, 56201
- Rice Memorial Hospital
-
-
Missouri
-
Osage Beach, Missouri, Stati Uniti, 65065
- Lake Regional Hospital
-
St Louis, Missouri, Stati Uniti, 63131
- Missouri Baptist Medical Center
-
-
North Carolina
-
Gastonia, North Carolina, Stati Uniti, 28054
- CaroMont Regional Medical Center
-
Lincolnton, North Carolina, Stati Uniti, 28092
- CaroMont Health - Lincoln Cancer Center
-
Pinehurst, North Carolina, Stati Uniti, 28374
- FirstHealth of the Carolinas-Moore Regional Hospital
-
Rocky Mount, North Carolina, Stati Uniti, 27804
- Nash UNC HealthCare
-
-
Ohio
-
Belpre, Ohio, Stati Uniti, 45714
- Strecker Cancer Center-Belpre
-
Lancaster, Ohio, Stati Uniti, 43130
- Fairfield Medical Center
-
Lima, Ohio, Stati Uniti, 45801
- Saint Rita's Medical Center
-
Marietta, Ohio, Stati Uniti, 45750
- Marietta Memorial Hospital
-
Newark, Ohio, Stati Uniti, 43055
- Licking Memorial Hospital
-
Portsmouth, Ohio, Stati Uniti, 45662
- Southern Ohio Medical Center
-
Zanesville, Ohio, Stati Uniti, 43701
- Genesis Healthcare System Cancer Care Center
-
-
South Carolina
-
Boiling Springs, South Carolina, Stati Uniti, 29316
- Prisma Health Cancer Institute - Spartanburg
-
Easley, South Carolina, Stati Uniti, 29640
- Prisma Health Cancer Institute - Easley
-
Greenville, South Carolina, Stati Uniti, 29605
- Prisma Health Cancer Institute - Faris
-
Greenville, South Carolina, Stati Uniti, 29615
- Prisma Health Cancer Institute - Eastside
-
Greenville, South Carolina, Stati Uniti, 29605
- Prisma Health Cancer Institute - Butternut
-
Greer, South Carolina, Stati Uniti, 29650
- Prisma Health Cancer Institute - Greer
-
Seneca, South Carolina, Stati Uniti, 29672
- Prisma Health Cancer Institute - Seneca
-
-
Virginia
-
Chesapeake, Virginia, Stati Uniti, 23320
- Chesapeake Regional Medical Center
-
-
Wisconsin
-
Green Bay, Wisconsin, Stati Uniti, 54301
- Saint Vincent Hospital Cancer Center Green Bay
-
Green Bay, Wisconsin, Stati Uniti, 54303
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
Sturgeon Bay, Wisconsin, Stati Uniti, 54235-1495
- Saint Vincent Hospital Cancer Center at Sturgeon Bay
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Have a diagnosis of cancer
- Have received neurotoxic chemotherapy within the past nine months (could still be on chemotherapy or have already completed chemotherapy; i.e., taxane-, platinum-, vinca alkaloid-, epothilone-, or proteasome inhibitor-based chemotherapy
- Report one or more symptoms of CIPN at a level of >= 4 on the CIPN symptom inventory on the Screening Form
- Have an Eastern Cooperative Oncology Group (ECOG) performance status 0-1
- Have at least six months life expectancy
- Be at least 18 years of age
- Be able to read and understand English
- Be able to provide written informed consent
Exclusion Criteria:
- Have physical limitations (e.g., cardiorespiratory, orthopedic, central nervous system) that contraindicate participation in a low to moderate intensity home-based walking and progressive resistance exercise program, according to the participant's physician (e.g., oncologist, primary care) or physician's designee
- Be identified as in the active or maintenance stage of exercise behavior per the Exercise Stages of Change Question on the Screening Form
- Have planned surgery or radiation treatment during the course of the study (hormonal and biologic therapy is allowed)
- Have contraindications for MRI scanning, per the MRI safety screening procedures of the MRI facility to be utilized for this participant
- Are pregnant of have plans to become pregnant during the course of the study. Documentation of pregnancy and use of contraception can be obtained from the medical record.
- Have a current or prior cancer in the central nervous system (spine, brainstem, brain) as this would interfere with assessments of brain functional connectivity.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Arm 1 (EXCAP, tactile sensitivity test, counseling)
Participants undergo the EXCAP intervention consisting of a home-based, self-directed, individually tailored progressive walking and resistance program for up to 6 weeks. Participants also undergo a tactile sensitivity test at baseline and after completion of EXCAP over 15-25 minutes. In addition, participants meet with a certified exercise instructor over 45 minutes at baseline and 2 additional booster meetings over 15-30 minutes during weeks 2 and 3 or weeks 4 and 5. Participants may optionally undergo MRI on study. |
Undergo MRI
Altri nomi:
Ancillary studies Meet with certified exercise instructor Participate in the EXCAP program Undergo tactile sensitivity test
Altri nomi:
|
|
Comparatore attivo: Arm 2 (usual care, tactile sensitivity test)
Participants receive usual care for 6 weeks. At the end of the study, participants may receive the exercise kit and complete the EXCAP program as in Arm 1. Participants also undergo a tactile sensitivity test at baseline and after completion of EXCAP over 15-25 minutes. Participants may optionally undergo MRI on study. |
Undergo MRI
Altri nomi:
Ancillary studies Meet with certified exercise instructor Participate in the EXCAP program Undergo tactile sensitivity test
Altri nomi:
Receive standard of care
Altri nomi:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Chemotherapy-induced peripheral neuropathy (CIPN) symptom severity
Lasso di tempo: Week 6 post randomization
|
Will estimate the effects of exercise versus usual care on CIPN using analysis of covariance (ANCOVA). Will be measured by the mean European Organization for Research and Treatment of Cancer-CIPN20. The model will include CIPN-20 at Week 6 as the outcome, treatment group (exercise vs. usual care) as the independent variable of interest and the pre-intervention CIPN-20 score as a covariate. |
Week 6 post randomization
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Effects of exercise on the severity of CIPN symptoms
Lasso di tempo: Up to 6 weeks post randomization
|
We will estimate the effects of exercise vs. usual care on CIPN symptoms (i.e., hot/burning or sharp/shooting pain in the hands or feet, numbness or tingling in the hands or feet) collected from the daily symptom inventory (0-10 severity) using analysis of covariance (ANCOVA). The model will include the average of daily symptom inventory for each CIPN symptom at post-intervention as the outcome, controlling for the average of daily symptom inventory for each CIPN symptom at pre-intervention. |
Up to 6 weeks post randomization
|
|
Effects of exercise on tactile sensitivity
Lasso di tempo: Up to 6 weeks post randomization
|
We will estimate the effects of exercise vs. usual care on tactile sensitivity in the fingers and toes, assessed via an established touch test procedure with a set of monofilaments, using analysis of covariance (ANCOVA). The model will include the tactile sensitivity score at post-intervention as the outcome, controlling for the pre-intervention score. |
Up to 6 weeks post randomization
|
|
Effect of exercise on interoception
Lasso di tempo: Up to 6 weeks post randomization
|
We will estimate the effects of exercise vs. usual care on interoception, measured via the Multidimensional Assessment of Interoceptive Awareness version 2 (MAIA-2), using analysis of covariance (ANCOVA). The model will include the MAIA-2 total score at post-intervention as the outcome, controlling for the pre-intervention MAIA-2 total score. |
Up to 6 weeks post randomization
|
Collaboratori e investigatori
Collaboratori
Investigatori
- Investigatore principale: Ian R Kleckner, University of Rochester NCORP Research Base
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
- Neoplasie per sede
- Neoplasie
- Malattie ematologiche
- Malattie emiche e linfatiche
- Neoplasie ematologiche
- Amministrazione dei servizi sanitari
- Qualità, accesso e valutazione dell'assistenza sanitaria
- Tecniche investigative
- Terapie
- Qualità dell'assistenza sanitaria
- Indicatori di qualità, assistenza sanitaria
- Tecniche di chimica, analitiche
- Analisi dello spettro
- Controllo del comportamento
- Immobilizzazione
- Linee guida come argomento
- Assicurazione della qualità, assistenza sanitaria
- Standard di cura
- Spettroscopia di risonanza magnetica
- Moderazione, fisico
- Pratica le linee guida come argomento
Altri numeri di identificazione dello studio
- URCC19075
- UG1CA189961 (Sovvenzione/contratto NIH degli Stati Uniti)
- URCC19075 (Altro identificatore: University of Rochester NCORP Research Base)
- NCI-2020-11456 (Identificatore di registro: CTRP (Clinical Trial Reporting Program))
- URCC-19075 (Altro identificatore: CTEP)
- R21CA256154 (Sovvenzione/contratto NIH degli Stati Uniti)
- URCC-19075 (Altro identificatore: DCP)
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .